NCT00185159View on ClinicalTrials.gov

Olmesartan Medoxomil in Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

4,449

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Diabetes Mellitus, Type 2Cardiovascular DiseaseKidney Disease
Interventions
DRUG

Olmesartan medoxomil

tablets

DRUG

Placebo Tablets

Tablets

Trial Locations (1)

Unknown

Darmstadt

All Listed Sponsors
lead

Sankyo Pharma Gmbh

INDUSTRY

NCT00185159 - Olmesartan Medoxomil in Diabetes Mellitus | Biotech Hunter | Biotech Hunter